Immunogenicity: The FDA classified BPC-157 in Category 2 for bulk drug substances, citing possible safety issues in compounding (immunogenicity, impurities, and insufficient safety evidence for suggested administration routes)
Biphasic response means GHK-Cu shows different effects at different doses
It acted via non-competitive inhibition, binding to non-active sites and inducing structural rearrangements, with reduced -helical content and increased -sheet and random coil, thereby disrupting ACE function without active-site competition
The resulting histamine backlog causes widespread vasodilation (expanding of the blood vessels), leading to rapid drops in blood pressure
GLUT4, an insulin dependent glucose transporter, shows a slight decrease in the secretory endometrium compared to proliferative endometrium (25)